EGFR inhibitor drugs have proven to be effective in treating several types of cancers, but they can come with uncomfortable side effects. Here’s what you should know.
Diversity Plans: Are you ready? It is widely discussed that the clinical trial industry suffers from a lack of diversity in clinical trial outcomes. “Diversity” represents a wide-range of descriptions, such as race and ethnicity, sex, gender identity, age, socioeconomic status, and disability status, to name a few. The FDA has issued several sets of...
M&B Sciences Inc Acquires Clara Health and Announces Goal to Become a Leader in Patient Recruitment and Retention in Clinical Trials March 09, 2022 09:29 AM Eastern Standard Time SAN DIEGO, Calif.–(BUSINESS WIRE)–M&B Sciences Inc, a fast-growing African-American owned, technology-driven clinical research organization, announces the acquisition of Clara Health, a company dedicated to using technology...